INDENTURE BETWEENIndenture • September 6th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
ANDLoan Agreement • September 6th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
MORTGAGE FROMElite Pharmaceuticals Inc /De/ • September 6th, 2005 • Pharmaceutical preparations
NOTE (Series B)Elite Pharmaceuticals Inc /De/ • September 6th, 2005 • Pharmaceutical preparations • New Jersey
This Note is issued to evidence the obligation of the Borrower and pursuant to, and shall be governed by and construed in accordance with, the terms and conditions of the Loan Agreement (as hereinafter defined) for the repayment of the Loan in the amount of $495,000 made by the Authority to the Borrower thereunder from the proceeds of the Authority's $495,000 Economic Development Bonds (Elite Pharmaceuticals, Inc. - 2005 Project), Federally Taxable Series B (the "Bonds") and the payment of interest thereon, including provision for repayment of the Loan in certain cases. All capitalized words and terms not defined herein shall have the respective meanings and be construed herein as provided in the Loan Agreement.
NOTE (Series A)Note • September 6th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
This Note is issued to evidence the obligation of the Borrower and pursuant to, and shall be governed by and construed in accordance with, the terms and conditions of the Loan Agreement (as hereinafter defined) for the repayment of the Loan in the amount of $3,660,000 made by the Authority to the Borrower thereunder from the proceeds of the Authority's $3,660,000 Economic Development Bonds (Elite Pharmaceuticals, Inc. - 2005 Project), Series A (the "Bonds") and the payment of interest thereon, including provision for repayment of the Loan in certain cases. All capitalized words and terms not defined herein shall have the respective meanings and be construed herein as provided in the Loan Agreement.
